Clinical Trials Browser

Papillomavirus Infections × Gynecologic × 30 days × Clear all

NCT07428330 2026-05-22

CASCADE3001A

Phase NA Recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07593066 2026-05-18

PRIORITY

Not yet recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07572396 2026-05-14

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Phase 2 Recruiting

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT06498661 2026-05-13

SHIP-A-S01

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03726151 2026-05-12

Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

Phase NA Completed

17,000 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07545746 2026-05-11

ASCEND

Phase 2 Not yet recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections